NCT07569367 · NOT YET RECRUITING

A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum

This study is testing whether wearable sensors and digital assessments can reliably track symptoms and daily functioning in people with frontotemporal dementia and related conditions. Participants wear sensors and complete computerized tests over 24 months, with check-ins every 6 months. The goal is to develop better measurement tools for these diseases, not to test a drug or treatment. The phase is unspecified, so this is early-stage validation work.

You may qualify if

  • Male and female participants aged 40 years or older with a clinical diagnosis of possible or probable FTLD syndrome phenotype.
  • Participants must be fluent in reading and speaking English and must be capable of providing informed consent based on the principal investigator's judgment.
  • Individuals eligible for inclusion must be able to comply with the protocol per the investigator's judgment and must have a caregiver or study partner who is willing and able to assist with all study-related procedures.

You're excluded if

  • Any neurological, medical, or psychiatric condition that would preclude or confound participation in study activities based on the investigator's judgment.
  • Individuals who have a history of frequent falls defined as more than 5 falls per month.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-05-06

View full record on ClinicalTrials.gov

All APOE4 clinical trials